Literature DB >> 17029219

SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma.

C P-Y Lau1, R T-P Poon, S-T Cheung, W-C Yu, S-T Fan.   

Abstract

Both Secreted Protein Acidic and Rich in Cysteine (SPARC) and Hevin are multifunctional matricellular glycoproteins. Recent experimental studies suggested that Hevin and SPARC together diminish angiogenesis, but their significance in hepatocellular carcinoma (HCC) remains unclear. This study aimed to correlate SPARC and Hevin expression with angiogenesis and clinicopathological features in HCC. SPARC and Hevin protein and mRNA expression in HCC specimens were assessed by immunostaining, immunoblotting, and quantitative reverse transcriptase-polymerase chain reaction. Tumour microvessel density (MVD) was assessed by CD34 immunostaining. The role of SPARC and Hevin in HCC was further assessed in an in vivo nude mice xenograft model. Both SPARC and Hevin mRNA levels were significantly higher in tumours than in non-tumourous livers. A significant correlation between tumour SPARC and Hevin mRNA levels was found. Moreover, SPARC protein localized in the tumour sinusoidal area correlated significantly with Hevin protein localized in HCC cells. Truncated forms of SPARC and Hevin proteins were detected in clinical samples. Truncated SPARC protein localized in the tumour sinusoidal area correlated significantly with tumour MVD. On the other hand, overexpression of full-length SPARC in tumour xenografts in athymic nude mice significantly delayed tumour growth, and this delay was related to a decrease in tumour angiogenesis. Expression of Hevin protein within HCC cells was related to the presence of tumour encapsulation and the absence of hepatitis B surface antigen in clinical samples. Overexpression of Hevin in tumour xenografts also significantly delayed tumour growth. In conclusion, this study has shown that SPARC and Hevin are upregulated in HCC compared with non-tumourous liver, and that they are inter-related at both mRNA and protein levels. Moreover, both SPARC and Hevin were related to HCC angiogenesis and tumour progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17029219     DOI: 10.1002/path.2068

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  33 in total

1.  SPARCL1: a potential molecule associated with tumor diagnosis, progression and prognosis of colorectal cancer.

Authors:  Hong Zhang; Emma Widegren; Da-Wei Wang; Xiao-Feng Sun
Journal:  Tumour Biol       Date:  2011-09-02

Review 2.  Insidious changes in stromal matrix fuel cancer progression.

Authors:  Fayth L Miles; Robert A Sikes
Journal:  Mol Cancer Res       Date:  2014-01-22       Impact factor: 5.852

3.  Proteolysis of the matricellular protein hevin by matrix metalloproteinase-3 produces a SPARC-like fragment (SLF) associated with neovasculature in a murine glioma model.

Authors:  Matt Weaver; Gail Workman; Chad R Schultz; Nancy Lemke; Sandra A Rempel; E Helene Sage
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

Review 4.  Anti-cancer role of SPARC, an inhibitor of adipogenesis.

Authors:  Ganji Purna Chandra Nagaraju; Dipali Sharma
Journal:  Cancer Treat Rev       Date:  2011-01-14       Impact factor: 12.111

5.  Processing of the matricellular protein hevin in mouse brain is dependent on ADAMTS4.

Authors:  Matt S Weaver; Gail Workman; Marina Cardo-Vila; Wadih Arap; Renata Pasqualini; E Helene Sage
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

6.  Increased invasiveness and aggressiveness in breast epithelia with cytoplasmic p63 expression.

Authors:  Yi-Hsuan Hsiao; Yan A Su; Horng-Der Tsai; Jeffrey T Mason; Ming-Chih Chou; Yan-gao Man
Journal:  Int J Biol Sci       Date:  2010-08-08       Impact factor: 6.580

7.  A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma.

Authors:  Raghothama Chaerkady; H C Harsha; Anuradha Nalli; Marjan Gucek; Perumal Vivekanandan; Javed Akhtar; Robert N Cole; Jessica Simmers; Richard D Schulick; Sujay Singh; Michael Torbenson; Akhilesh Pandey; Paul J Thuluvath
Journal:  J Proteome Res       Date:  2008-08-21       Impact factor: 4.466

8.  Microarray-based cancer prediction using soft computing approach.

Authors:  Xiaosheng Wang; Osamu Gotoh
Journal:  Cancer Inform       Date:  2009-05-26

9.  The role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine.

Authors:  P Bhoopathi; C Chetty; M Gujrati; D H Dinh; J S Rao; S S Lakka
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

10.  SPARC: a matricellular regulator of tumorigenesis.

Authors:  Shanna A Arnold; Rolf A Brekken
Journal:  J Cell Commun Signal       Date:  2009-10-07       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.